Literature DB >> 33459174

Withanolides from Withania somnifera as an immunity booster and their therapeutic options against COVID-19.

Pukar Khanal1, Rupesh Chikhale2, Yadu Nandan Dey3, Ismail Pasha4, Sharad Chand5, Nilambari Gurav6, Muniappan Ayyanar7, B M Patil1, Shailendra Gurav8.   

Abstract

Traditionally, Withania somnifera is widely used as an immune booster, anti-viral, and for multiple medicinal purposes. The present study investigated the withanolides as an immune booster and anti-viral agents against the coronavirus-19. Withanolides from Withania somnifera were retrieved from the open-source database, their targets were predicted using DIGEP-Pred, and the protein-protein interaction was evaluated. The drug-likeness score and intestinal absorptivity of each compound were also predicted. The network of compounds, proteins, and modulated pathways was constructed using Cytoscape, and docking was performed using autodock4.0, and selected protein-ligand complexes were subjected to 100 ns Molecular Dynamics simulations. The molecular dynamics trajectories were subjected to free energy calculation by the MM-GBSA method. Withanolide_Q was predicted to modulate the highest number of proteins, showed human intestinal absorption, and was predicted for the highest drug-likeness score. Similarly, combined network interaction identified Withanolide_Q to target the highest number of proteins; RAC1 was majorly targeted, and fluid shear stress and atherosclerosis associated pathway were chiefly regulated. Similarly, Withanolide_D and Withanolide_G were predicted to have a better binding affinity with PLpro, Withanolide_M with 3CLpro, and Withanolide_M with spike protein based on binding energy and number of hydrogen bond interactions. MD studies suggested Withanoside_I with the highest binding free energy (ΔGbind-31.56 kcal/mol) as the most promising inhibitor. Among multiple withanolides from W. somnifera, Withanolide_D, Withanolide_G, Withanolide_M, and Withanolide_Q were predicted as the lead hits based on drug-likeness score, modulated proteins, and docking score to boost the immune system and inhibit the COVID-19 infection, which could primarily act against COVID-19. HighlightsWithanolides are immunity boosters.Withanolides are a group of bio-actives with potential anti-viral properties.Withanolide_G, Withanolide_I, and Withanolide_M from Withania somnifera showed the highest binding affinity with PLpro, 3CLpro, and spike protein, respectively.Withanolides from Withania somnifera holds promising anti-viral efficacy against COVID-19.Communicated by Vsevolod Makeev.

Entities:  

Keywords:  Anti-viral; COVID-19; Withania somnifera; immunomodulator; withanolides

Mesh:

Substances:

Year:  2021        PMID: 33459174     DOI: 10.1080/07391102.2020.1869588

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102            Impact factor:   5.235


  13 in total

1.  Screening of JAK-STAT modulators from the antiviral plants of Indian traditional system of medicine with the potential to inhibit 2019 novel coronavirus using network pharmacology.

Authors:  Ismail Pasha; Rohini S Kavalapure; Sharad Chand; Shailendra Gurav; Pukar Khanal; Taaza Duyu; B M Patil; Yadu Nandan Dey
Journal:  3 Biotech       Date:  2021-02-08       Impact factor: 2.406

2.  GLUT-2 mediated glucose uptake analysis of Duranta repens: In-silico and In-vitro approach.

Authors:  Ashwini Patil; Prarambh S R Dwivedi; Soham Naik Gaonkar; Vrunda Kumbhar; Vaishnavi Shankar Madiwalar; Pukar Khanal; B M Patil
Journal:  J Diabetes Metab Disord       Date:  2022-02-14

3.  An In-vitro evaluation of a polyherbal formulation, against SARS-Cov-2.

Authors:  Divya Kanchibhotla; Saumya Subramanian; Reddy M Ravi Kumar; K R Venkatesh Hari; Monika Pathania
Journal:  J Ayurveda Integr Med       Date:  2022-06-23

4.  Computational and network pharmacology studies of Phyllanthus emblica to tackle SARS-CoV-2.

Authors:  Rupesh V Chikhale; Saurabh K Sinha; Pukar Khanal; Nilambari S Gurav; Muniappan Ayyanar; Satyendra K Prasad; Manish M Wanjari; Rajesh B Patil; Shailendra S Gurav
Journal:  Phytomed Plus       Date:  2021-07-13

Review 5.  Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19.

Authors:  Rajeshwari Singh; Sumeet Goel; Pascale Bourgeade; Lotfi Aleya; Devesh Tewari
Journal:  Environ Sci Pollut Res Int       Date:  2021-09-07       Impact factor: 5.190

6.  Identification of PTP1B regulators from Cymbopogon citratus and its enrichment analysis for diabetes mellitus.

Authors:  Prarambh S R Dwivedi; Pukar Khanal; Vishakha Parab Gaonkar; V P Rasal; B M Patil
Journal:  In Silico Pharmacol       Date:  2021-04-11

Review 7.  Ginseng, a promising choice for SARS-COV-2: A mini review.

Authors:  Zubair Ahmed Ratan; Fazla Rabbi Mashrur; Nusrat Jahan Runa; Ki Woong Kwon; Hassan Hosseinzadeh; Jae Youl Cho
Journal:  J Ginseng Res       Date:  2022-01-22       Impact factor: 5.735

8.  Combination of system biology to probe the anti-viral activity of andrographolide and its derivative against COVID-19.

Authors:  Pukar Khanal; Yadu Nandan Dey; Rajesh Patil; Rupesh Chikhale; Manish M Wanjari; Shailendra S Gurav; B M Patil; Bhavana Srivastava; Sudesh N Gaidhani
Journal:  RSC Adv       Date:  2021-01-27       Impact factor: 3.361

Review 9.  Rac1, A Potential Target for Tumor Therapy.

Authors:  Jiaxin Liang; Linda Oyang; Shan Rao; Yaqian Han; Xia Luo; Pin Yi; Jinguan Lin; Longzheng Xia; Jiaqi Hu; Shiming Tan; Lu Tang; Qing Pan; Yanyan Tang; Yujuan Zhou; Qianjin Liao
Journal:  Front Oncol       Date:  2021-05-17       Impact factor: 6.244

10.  Gene set enrichment analysis of PPAR-γ regulators from Murraya odorata Blanco.

Authors:  Ekta Kotharkar; Shailaja Nare; Prarambh Sr Dwivedi; V P Rasal; Pukar Khanal
Journal:  J Diabetes Metab Disord       Date:  2021-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.